HORSHAM, PA, USA—SEPTEMBER 24, 2012— DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide will host the Global Labeling 2012: Impact on Risk Management & Other Global and Regional Initiatives conference on October 11-12 at Silver Spring Civic Building in Silver Spring, MD. This two-day conference will focus on the current role of labeling and how to implement risk management initiatives on labeling components in the near future, as well as how effective current labeling is to patients and prescribers and examining global, current hot topics.
This conference offers attendees a plethora of speakers from global labeling perspectives that are intent on reconfiguring the current and future standards. Hear presentations on labeling in EU, Canada, Japan and US, effectiveness of labeling components, global labeling documents, study endpoints and labeling developments, patient labeling guidelines, risk management, as well as networking.
“This meeting will help industry professionals comprehend the ever-changing landscape of global labeling within risk management and implementing the impending initiatives,” states Paul Pomerantz, DIA’s Worldwide Executive Director. “It is apparent that the ideas and views discussed with lend a better understanding in the daily lives of and the conference attendees in all areas of the globe.”
Register for the Global Labeling 2012: Impact on Risk Management & Other Global and Regional Initiatives here.
About DIA
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. Follow DIA on Facebook, Twitter, LinkedIn, and YouTube. Stay updated on hot topic news at #druginfoassn on Twitter.
